Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Roni Bollag"'
Autor:
Huabin Zhu, Anuj K. Sharma, Karina Aguilar, Faizan Boghani, Semih Sarcan, Michelle George, Janavi Ramesh, Joshua Van Der Eerden, Chandramukhi S. Panda, Aileen Lopez, Wenbo Zhi, Roni Bollag, Nikhil Patel, Kandace Klein, Joe White, Muthusamy Thangaraju, Bal L. Lokeshwar, Nagendra Singh, Vinata B. Lokeshwar
Publikováno v:
iScience, Vol 27, Iss 3, Pp 109191- (2024)
Summary: The paucity of preclinical models that recapitulate COVID-19 pathology without requiring SARS-COV-2 adaptation and humanized/transgenic mice limits research into new therapeutics against the frequently emerging variants-of-concern. We develo
Externí odkaz:
https://doaj.org/article/3877c862934c43f0957472d97369ba13
Autor:
Shuaishuai Wang, Congcong Chen, Madhusudhan Reddy Gadi, Varma Saikam, Ding Liu, He Zhu, Roni Bollag, Kebin Liu, Xi Chen, Fengshan Wang, Peng George Wang, Peixue Ling, Wanyi Guan, Lei Li
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Abstract O-GalNAc glycans (or mucin O-glycans) play pivotal roles in diverse biological and pathological processes, including tumor growth and progression. Structurally defined O-GalNAc glycans are essential for functional studies but synthetic chall
Externí odkaz:
https://doaj.org/article/3a64e407ac464a248e796f18a724fe06
Autor:
Gang Zhou, David H Munn, Zhi-Chun Ding, Marco L Davila, Hongyan Xu, Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Gregory Gorman, Roni Bollag, Locke J Bryan, Gary A Piazza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background Adoptive cell therapy (ACT) using genetically modified T cells has evolved into a promising treatment option for patients with cancer. However, even for the best-studied and clinically validated CD19-targeted chimeric antigen receptor (CAR
Externí odkaz:
https://doaj.org/article/a814f619a9934bacafbe74860b95a4f2
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract Fibroblastic reticular cells (FRCs) in the T cell zone of lymph nodes (LNs) are pivotal for T cell survival, mobility, and peripheral tolerance. Here, we demonstrate that during homeostasis, FRCs also suppress T cell activation via producing
Externí odkaz:
https://doaj.org/article/0bd5ba7415d8496fa9f90849dd1b3690
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:PCL22-186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1a80702568ca1cda5b551a04ebb8c7e
https://doi.org/10.6004/jnccn.2021.7171
https://doi.org/10.6004/jnccn.2021.7171
Autor:
Nada S Aboelella, Caitlin Brandle, Ogacheko Okoko, Md Yeashin Gazi, Zhi-Chun Ding, Hongyan Xu, Gregory Gorman, Roni Bollag, Marco L Davila, Locke J Bryan, David H Munn, Gary A Piazza, Gang Zhou
Publikováno v:
Journal for immunotherapy of cancer. 10(7)
BackgroundAdoptive cell therapy (ACT) using genetically modified T cells has evolved into a promising treatment option for patients with cancer. However, even for the best-studied and clinically validated CD19-targeted chimeric antigen receptor (CAR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e599ec3d9ead270f2101a6ca9d8fbb
https://pubmed.ncbi.nlm.nih.gov/35882449
https://pubmed.ncbi.nlm.nih.gov/35882449
Autor:
Maxine S. Harlemon, Roni Bollag, Martha Terris, Ana Cecilia Millena, Nathan Bowen, Valerie Odero-Marah
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 32:C044-C044
Prostate cancer is the most common non-cutaneous cancer among men. A man with 1,2 or 3 first degree relatives with prostate cancer, has a 2,5, and 11-fold increased risk of developing prostate cancer. The heritability rate of prostate cancer is 58%.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96216afb08146816cf647f1ad502dbb9
https://doi.org/10.1158/1538-7755.disp22-c044
https://doi.org/10.1158/1538-7755.disp22-c044
Autor:
Chandra S. Amara, Chandrashekar R. Ambati, Venkatrao Vantaku, Piyarathna W b Danthasinghe, Sri Ramya Donepudi, Shiva S. Ravi, James M. Arnold, Vasantha Putluri, Gurkamal Chatta, Khurshid A. Guru, Hoda Badr, Martha K. Terris, Roni Bollag, Arun Sreekumar, Andrea B. Apolo, Nagireddy Putluri
Publikováno v:
Cancer Research. 79:2217-2217
Urinary bladder cancer (BLCA) is the 9th most common malignant disease and the 13th most common cause of cancer death worldwide. Occupational exposure to carcinogens has been long associated with increased BLCA risk. Tobacco smoke contains more than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e70fadec7ebfe99287db5463b163c2e3
https://doi.org/10.1158/1538-7445.am2019-2217
https://doi.org/10.1158/1538-7445.am2019-2217
Publikováno v:
Acta cytologica. 54(3)
Anaplastic large cell lymphoma (ALCL) is an uncommon hematolymphoid neoplasm characterized by malignant lymphocytes of T-cell phenotype. It usually affects young patients and may involve a variety of tissues and organs. We herein describe a case of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ee4e32a68438e92e8eaa1b9cfcdee43d
https://pubmed.ncbi.nlm.nih.gov/20518421
https://pubmed.ncbi.nlm.nih.gov/20518421